Li-you Lian

Li-you Lian


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2026 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
WLWenyue Liu
Wenyue Liu
LLLi-you Lian
Li-you Lian
Seung Up KimSeung Up Kim
Seung Up Kim
Terry Cheuk-Fung YipTerry Cheuk-Fung Yip
Terry Cheuk-Fung Yip
SPSalvatore Petta
Salvatore Petta
MZMing-Hua Zheng
Ming-Hua Zheng
INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease, and liver biopsy remains the gold standard for diagnosis. However, a subset of patients diagnosed with MASLD by imaging paradoxically exhibit steatosis grade S0 on liver biopsy, posing a diagnostic challenge. This study investigated the outcomes and causes of steatosis 0. METHODS: Steatosis 0 was defined as imaging-detected MASLD with a biopsy-defined steatosis grade S0. We used global cohorts to evaluate outcomes, histologic progression by paired biopsies, and possible causes. The cause analysis included MRI-proton density fat fraction (MRI-PDFF) for fat distribution, pathologist consistency testing, and comparison of serial biopsy sections. RESULTS: In a follow-up cohort of 3,273 biopsy individuals from 16 centers, 123 (3.8%) exhibited steatosis 0. Of these, 29.3% of them had advanced fibrosis (burnt-out MASLD) and demonstrated a risk of liver-related events, whereas those without advanced fibrosis had no such events. In the paired-biopsy cohort of 1,865 patients, 74 (4.0%) individuals initially showed steatosis grade S0; among them, 93.2% retained no or mild steatosis on follow-up biopsy. MRI-PDFF assessments in 42 MASLD patients revealed heterogeneous hepatic fat distribution, with some segments showing steatosis grade S0 despite elevated average liver fat. Interpathologist variability and discrepancies across consecutive biopsy sections contributed to misclassification of steatosis grade. DISCUSSION: Steatosis 0 represents a potential diagnostic gray zone in MASLD. It may be caused by burnt-out MASLD, uneven liver fat distribution, or variability in pathological assessment. Understanding the causes and implications of steatosis 0 is critical for diagnosis and management.

2 March 2026 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
CCChen Chen
Chen Chen
YZYaoxue Zang
Yaoxue Zang
ZNZiyi Ni
Ziyi Ni
QZQianli Zhu
Qianli Zhu
GXGuangze Xiang
Guangze Xiang
YLYinuo Lin
Yinuo Lin